PLT Health Solutions, Inc is staging a European launch of its new breakthrough sleep category ingredient called Serezin™ Restorative Sleep + Pain Relief at Vitafoods Europe on 14 May at Booth G141. In addition, the company will highlight ingredients with new clinical studies in joint health, cognitive performance and weight management. In a randomised, double-blind, placebo-controlled clinical trial, users of Serezin were shown to improve sleep across a wide range of measures, helping them get to sleep faster and easier, improve their quality sleep and helping them wake easier, more alert and in a better mood. The improved restorative sleep offered by Serezin has also been shown to decrease pain during the day. At Vitafoods. PLT’s booth will be staffed by members from its sales, marketing and scientific teams in support of the company’s growing presence in Europe and other global markets.
According to Steve Fink, VP of Marketing for PLT Health Solutions, Serezin represents a unique approach to the sleep ingredients market. "Rather than making them drowsy, Serezin addresses the issue of nighttime aches and pains that prevent people from getting good sleep. Clinical data shows that it helps us achieve what’s known as ‘restorative sleep’, giving us the experience of a good night’s rest.
At PLT, we're very excited to be introducing Serezin to the European market after more than three years in development with our partner Laila Nutraceuticals. We are proud of the strength of our clinical data to support messaging related to these consumer needs,” he said.
Serezin Highlights a Series of New Clinical Studies
Serezin Restorative Sleep + Pain Relief has been clinically demonstrated to improve sleep across a wide range of measures, helping people get to sleep faster and easier, improve their quality sleep and helping them wake easier, more alert and in a better mood. The improved restorative sleep offered by Serezin has also been shown to decrease pain during the day. A comprehensive 4-week, double-blind, placebo-controlled study was conducted on 60 healthy men and women ages 40-70 years. Subjects self-reported disturbed sleep due to everyday aches and pains. They received either a 300 mg dose of Serezin a day or a placebo. Serezin subjects experienced a 64% greater improvement in restorative sleep, an 85% greater ability to fall asleep and a 2.6x greater reduction in nighttime discomfort than subjects taking a placebo. Serezin subjects also woke up easier and in a better mood.
Other clinically studied ingredients being feratured at Vitafoods Europe includes:
AprèsFlex® 5-Day Joint Support – A 6-monthy study showed long-term and continuing benefits. It also demonstrated joint space improvement and cartilage preservation and protection. Science-backed cartilage health is a major innovation with this ingredient.
Slendacor® Weight Management Complex – A clinical trial demonstrated increased resting metabolic rate, thermogenic effects and calorie burning in addition to metabolic health benefits. The ingredient was recently granted a patent based on this new clinical data.
Nutricog® Cognitive Performance Complex - A 2023 study demonstrated multiple aspects of cognitive performance including faster learning, improved attention, better memory and reduced distractibility.
According to Rodolphe Hang, Business Development Director, EMEA, Vitafoods Europe is an important opportunity for PLT to share new ingredients, new science and new ideas with the European and global community. “Every year, PLT introduces new ingredients that are compliant in EU and global markets. But we are also investing in a range of resources that allow us to be a product development partner with consumer products companies. At Vitafoods 2024, we want the opportunity to share these developments with attendees,” he said.
The PLT stand will be #G141
For more information or to arrange a meeting at Vitafoods, visit www.plthealth.com
